Browsing by 저자 : Michelino De Laurentiis
전체 결과 6건 중 1-6 번을 표시중입니다.
-
1
Article
A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer
Sherko Kuemmel
;
Mario Campone
;
Delphine Loirat
;
et al
2022
-
2
Article
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study
정경해
;
Alexandra Hogea
;
Andre Mattar
;
et al
2021
-
3
Article
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study
정경해
;
Alexandra Hogea
;
Andre Mattar
;
et al
2021
-
4
Article
Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study
Joseph Gligorov
;
Xavier Pivot
;
Beyhan Ataseven
;
et al
2022
-
5
Article
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial
김성배
;
Aruna Mani
;
Chiara Lambertini
;
et al
2020
-
6
Article
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
Yen-Shen Lu
;
Seock-Ah Im
;
Marco Colleoni
;
et al
2022